Stock market today: S&P 500 surges as big tech earnings spurs fresh AI optimism

Published 01/05/2025, 01:24
Updated 01/05/2025, 21:04
© Reuters.

Investing.com -- The S&P 500 rose Thursday as robust earnings from Microsoft and Meta Platforms, provided fresh signs that the artificial intelligence boom is far from over, fueling gains across stocks. 

At 4:00 p.m. ET (20:00 GMT), the Dow Jones Industrial Average gained 82 points, or 0.6%, the S&P 500 index added 0.6%, and the NASDAQ Composite gained 1.5%.

Microsoft, Meta surge after strong Q1 results

Meta Platforms (NASDAQ:META) shares jumped more than 4% after quarterly results and guidance topped consensus. The parent company of Facebook and Instagram anticipated full-year 2025 capital expenditures in the range of $64-$72 billion, increased from their prior guidance of $60-65 billion. 

"We believe the higher level of investment is justified, as the infusion of AI capabilities across the company’s ad stack and content recommendation engines are already driving tangible benefits for Meta’s Family of Apps and Reality Labs," Wedbush said in a Thursday note.

Microsoft (NASDAQ:MSFT) shares surged more than 7% after the software giant’s first-quarter revenue increased 13%. It also forecast cloud-computing revenue growth of 34% to 35% for the fiscal fourth quarter.

"Microsoft surprised with a much better-than-expected top-line performance, saying that through late-April they had not seen any material demand pressure from the macro/tariff issues," RBC said in a Thursday note.

There are more corporate earnings to digest Thursday, with the highlights being from iPhone-maker Apple (NASDAQ:AAPL) and e-commerce titan Amazon (NASDAQ:AMZN) after the close.

Elsewhere, McDonald’s (NYSE:MCD) stock fell more than 1% after the fast food giant posted a surprise decline in first-quarter global comparable sales, with CEO Chris Kempczinski adding the company was navigating the "toughest of market conditions."

Eli Lilly (NYSE:LLY) stock dropped 11% after the drugmaker posted disappointing sales of its popular weight-loss drug, Zepbound.

Biogen (NASDAQ:BIIB) stock rose slightly after the drugmaker beat first-quarter profit and revenue expectations, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis drugs.

Estee Lauder (NYSE:EL) stock fell more than 11% after flagging ongoing challenges in its travel retail business and subdued consumer sentiment in Asia.

Initial claims rise

The number of Americans filing new applications for unemployment benefits increased more than expected last week, as initial claims for state unemployment benefits jumped 18,000 for the week ended April 26, the Labor Department said on Thursday. 

This potentially hinted at a pick-up in layoffs from tariffs, which weighed on the economy in the first quarter, ahead of Friday’s key nonfarm payrolls report.

The economy contracted last quarter for the first time in three years, swamped by a flood of imports as businesses tried to avoid duties from President Donald Trump’s tariffs.

(Ayushman Ojha contributed to this article.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.